Shares of NIOX Group Plc (LON:NIOX - Get Free Report) rose 21.1% on Thursday . The company traded as high as GBX 76.80 ($0.99) and last traded at GBX 73.60 ($0.95). Approximately 4,285,667 shares traded hands during mid-day trading, an increase of 457% from the average daily volume of 769,364 shares. The stock had previously closed at GBX 60.80 ($0.79).
NIOX Group Stock Down 1.1 %
The company has a current ratio of 6.31, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10. The firm has a market cap of £29.98 billion, a price-to-earnings ratio of 3,012.58 and a beta of 0.92. The firm has a 50 day moving average price of GBX 62.23 and a 200-day moving average price of GBX 63.49.
NIOX Group Company Profile
(
Get Free Report)
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.
See Also
Before you consider NIOX Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NIOX Group wasn't on the list.
While NIOX Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
